Application of combination of isoxazole-9 and mesenchymal stem cells in preparation of medicine for preventing or treating acute lung injury

The invention provides application of isoxazole-9 combined mesenchymal stem cells in preparation of a medicine for preventing or treating acute lung injury. The application is used for preventing or treating the acute lung injury. The invention further provides application of the composition containing the isoxazole-9 and the mesenchymal stem cells in preparation of drugs for preventing or treating acute lung injury. The invention finds that ISX-9 can improve the ALI treatment capability of MSCs for the first time, and proves that ISX-9 can improve the duration and strength of the action of the mesenchymal stem cells in the lung and enhance the ALI treatment capability of the mesenchymal stem cells. The scheme has been verified in cell and mouse ALI models, and has potential clinical application value..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 19. Dez. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

FENG YUN [VerfasserIn]
HU XIAOYAN [VerfasserIn]
TIAN YI [VerfasserIn]
WANG CHEN [VerfasserIn]
XIE SIMIN [VerfasserIn]
GE XIAO [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
che

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-12-19, Last update posted on www.tib.eu: 2024-03-13, Last updated: 2024-03-22

Patentnummer:

CN117243977

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA000777498